Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...

Expects foreign currency exchange to have negative impact of $55M based on currency rates as of January 31, 2025; Labs business growth expected ...